Ophthalmology was one of the early adopters of artificial intelligence (AI) in medicine, and the increasing availability and quality of digital ophthalmic images and metrics continue to drive the development of deep learning (DL) algorithms. Insights from AI-based apps can empower physicians to identify disease earlier, differentiate conditions, and make informed treatment decisions in a wide range of ophthalmic diseases including glaucoma and age-related macular degeneration (AMD), as well as cataract and other anterior segment diseases.
Uncover Heidelberg AppWay – a secure gateway to ophthalmic apps
Heidelberg AppWay provides secure, simple, and seamless access to both clinical and research applications. Integrated into the HEYEX 2 ophthalmic image management platform, it is the only vendor-neutral workflow solution for the rapidly growing number of AI applications. Based on cloud exchange and application marketplace technologies, Heidelberg AppWay facilitates the transfer of diagnostic images to innovative app providers whose proprietary algorithms can yield deeper diagnostic insights from these images.* Whether the immediate need is to measure and visualize photoreceptor degeneration and RPE loss, quantify fluid, segment the retinal layers, or identify specific biomarkers, app-generated reports can support clinicians and researchers in detecting and monitoring vision-threatening eye disease over time and measuring the efficacy of treatments.
Uncover the power of AI-based analytics for the management of geographic atrophy
Recent approval by the US Food and Drug Administration (FDA) of new treatments for geographic atrophy, secondary to AMD, are once again underscoring the importance of multimodal imaging with SPECTRALIS® for mapping and tracking disease markers. Heidelberg AppWay now offers access to RetInSight GA Monitor – the first and only GA algorithm approved under the EU medical device regulation (MDR) for use in clinical routine. The GA Monitor offers a unique ability to measure and visualize photoreceptor degeneration (PR) and retinal pigment epithelium (RPE) loss and distinguish between slow and fast progressors.
“The exceptional image quality and rich data captured by our imaging platforms, in combination with these powerful analytics tools, provide eye care professionals with an unprecedented insight,” says Krysten Williams, Global Head of Marketing and Education at Heidelberg Engineering. “It empowers them to develop personalized treatment plans and educate patients to support compliance.”
Uncover the power to transform your clinical practice with AI-enhanced insights
The GA Monitor from RetInSight is the latest of several highly innovative analytics tools accessible through Heidelberg AppWay aiming to help make the invisible visible. RetInSight Fluid Monitor supports the visualization retinal fluid types and location automatically, including intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED), in real time with nanoliter precision over time.
Heidelberg AppWay also offers access to the RetinAI portfolio of AI tools for AMD, DME, and Cystoid Macula Edema. RetinAI is a Swiss company that develops software solutions to accelerate clinical, research, and pharmaceutical workflows. Reports generated in PDF format during the patient’s visit, are designed to complement the evaluation and management of retinal diseases. Clinical researchers can also find and subscribe to AI-based apps relevant to their projects in the various ophthalmic disciplines, including deepeye Medical and RetinAI pre-clinical applications. As Heidelberg AppWay is integrated into the HEYEX 2 environment, all relevant Heidelberg Engineering devices, as well as third party devices, can be displayed simultaneously in the HEYEX 2 Multimodality Viewer alongside reports generated by all app providers.
Based on the combination of Heidelberg Image Quality, comprehensive access to the multimodal diagnostic information from all Heidelberg Engineering devices, and deeper insights from a steadily increasing number of AI-based apps accessible through Heidelberg AppWay, HEYEX 2 supports fast, accurate assessment and leaves clinicians more time to consult with their patients. App-generated reports can be made available during the clinic visit and play a pivotal role in educating patients about their eye health, disease progression, and the need for compliance with treatment plans.
* Requires HEYEX 2 software version 2.6 or the standalone version plus registration for the GA Monitor app with app provider RetInSight.
Click below for more about
